Table 3 Dual Antiplatelet Therapy (DAPT) Medications at Discharge and the End of 1-year Follow-up.

From: Impact of Anemia and Dual Antiplatelet Therapy on Mortality in Patients Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stents

 

No Anemia

Mild Anemia

Moderate-severe Anemia

P Value

Medications at discharge

 Aspirin, n (%)

3163 (100.0)

866 (100.0)

80 (100.0)

 Clopidogrel, n (%)

3156 (99.8)

864 (99.8)

80 (100.0)

1.000

 Dual antiplatelet therapy, n (%)

3156 (99.8)

864 (99.8)

80 (100.0)

1.000

Medications at end of 1-year follow-up

 Aspirin, n (%)

2392 (88.4)

611 (82.6)

48 (73.8)

<0.001

 Clopidogrel, n (%)

2115 (78.2)

583 (78.8)

56 (86.2)

0.292

 Dual antiplatelet therapy, n (%)

1852 (68.4)

480 (64.9)

41 (63.1)

0.135

  1. *The number of patients at end of follow-up was 3511.